A CEO wears many hats—scientist, investor, operator—but their primary, non-delegable function is decision-making. This role requires integrating input from a leadership team that thinks at an enterprise level, enabling the CEO to make the final call on capital, strategy, and people.
Related Insights
A scientific background can be a major asset in a CEO role, not a liability. The core principles of science—making data-driven, rational, and unemotional decisions—translate directly to the business world. This allows for objective choices that align scientific development with the company's business needs.
A CEO's primary role differs fundamentally based on company type. In an asset-centric biotech, the CEO must act as a hands-on program manager, micromanaging execution. In a platform company, the CEO must be deeply embedded in the science to predict and leverage the technology's long-term trajectory.
CEO Oliver Karaz defines his role by three decision types: 1) hiring senior leaders he can trust to run their domains, 2) absorbing blame for calculated risks to encourage team innovation, and 3) integrating diverse inputs to set the company’s long-term 'where the puck is going' strategy.
Contrary to the popular advice to 'hire great people and get out of their way,' a CEO's job is to identify the three most critical company initiatives. They must then dive deep into the weeds to guarantee their success, as only the CEO has the unique context and authority to unblock them.
In the early stages, a biotech CEO's role is primarily scientific leadership and storytelling to attract investors. As the company and market mature, the role shifts. Effective CEOs must then become adaptable strategists, staying true to their core vision while responding to the dynamic industry environment.
Kevin Pojasek credits his effectiveness to a deliberate 12-year journey through diverse roles—investing, company creation, research, and clinical operations. This broad experience allows a leader to understand how all parts of the company, from high-level strategy to detailed science, fit together.
The ultimate differentiator for CEOs over decades isn't just product, but their skill as a capital allocator. Once a company generates cash, the CEO's job shifts to investing it wisely through M&A, R&D, and buybacks, a skill few are trained for but the best master.
Beyond scientific knowledge, the most effective biotech CEOs possess a specific set of traits. They must be decisive, maintain ruthless capital discipline (even for small amounts), and consistently demonstrate strategic clarity, especially when facing the immense pressure inherent in the industry.
Investor preference for CEOs has shifted dramatically. While 2019-2021 favored scientific founder-CEOs, today’s tough market demands leaders with prior CEO experience. The ideal candidate has a "matrix organization" background, understanding all business functions, not just the science.
A CEO's role is seeing the same company through the different lenses of various stakeholders (investors, lawyers, scientists). Success requires learning the unique 'language' of each group—their incentives and communication styles—to effectively translate the company's vision and value proposition for each audience.